IvelinRadkov Sanofi (NASDAQ:SNY) and Regeneron Pharmaeuticals (NASDAQ:REGN) Dupixent (dupiliumab), already a blockbuster drug approved for several indications, including asthma and…
Read More »Sanofi
Amidst economic uncertainty, high interest rates, talent shortages, and rising capital costs, artificial intelligence (AI) is top of mind for…
Read More »Â© Reuters. FILE PHOTO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France,…
Read More »